SMO Clinplus: Announcement regarding the proposal for mid-term dividend by the actual controller and chairman of the board of directors of the company in 2024.
SMO Clinplus: 301257 Pures research activity information on June 21, 2024.
SMO Clinplus: Articles of Association of Puris (Shanghai) Medical Technology Development Co., Ltd. (June 2024).
SMO Clinplus: 301257 Puyisi research activity information 20240605
SMO Clinplus: 301257 Pryce Research Activity Information20240517
SMO Clinplus: 301257 Prius Investor Relations Management Information 20240510
SMO Clinplus: 301257 Pryce Research Activity Information 20240430
SMO Clinplus: External guarantee decision management system (April 2024)
SMO Clinplus: Huatai United Securities Co., Ltd.'s inspection opinion on the extension of some fund-raising projects of Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd.
SMO Clinplus: Huatai United Securities Co., Ltd. inspection opinions on the storage and use of funds raised by Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd. in 2023
SMO Clinplus: On the 2023 Performance Evaluation Report of Accounting Firms
SMO Clinplus: The Board's special opinion on the sole director's independence assessment
SMO Clinplus: Notice on applying for credit lines from banks
SMO Clinplus: Announcement of Supervisory Board Resolutions
SMO Clinplus: Notice on changes in accounting policies
SMO Clinplus: Announcement of Board Resolutions
SMO Clinplus: Related Transaction Decision Management System (April 2024)
SMO Clinplus: Announcement on the company's renewal of the 2024 accounting firm
SMO Clinplus: Major Investment Decision Management System (April 2024)
SMO Clinplus: Independent Director Work System (April 2024)
No Data